110

Shares

GlaxoSmithKline and Google team up to create new bioelectronics health company

Shared by Radhika Narayanan | 0 92 18 | about 1 year ago

British pharmaceutical giant GlaxoSmithKline and Google’s parent company Alphabet have announced they’re creating a new company to develop bioelectronic medicines. The joint venture will be named Galvani Bioelectronics and will be headquartered in the UK, with 55 percent of equity interest owned by GSK and 45 percent owned by Alphabet’s Verily Life Sciences division (formerly known as Google Life Sciences). Galvani will initially be funded with £540 million over the next seven years ($712 million), and plans to have treatments ready for regulatory approval by 2023.

Read More On www.theverge.com

Categories Mergers, Partnerships & acquisitions Ventures

Related Post

Links

http://www.theverge.com/2016/8/1/12340454/gsk-google-bioelectronic-medicine-company
http://bit.ly/2awm27J

1 Votes

You must log in to post a comment

0 Comments